Laparoscopic Paraaortic Node Dissection for Cervical Cancer
Kenneth D. Hatch
Achim Schneider
GENERAL PRINCIPLES
Definition
Paraaortic node dissection in women who have cervical cancer is indicated for diagnostic (staging) or therapeutic reasons.
Women with stage 1B2 or 2A disease who are candidates for radical hysterectomy have a 6% to 12% risk of paraaortic node positivity. These women will benefit from paraaortic node dissection to eliminate the radical hysterectomy and allow the radiation therapist to cover all positive fields.
Women with stage 2B or above with negative nodes on PET/CT have up to a 35% chance of positive paraaortic nodes at the time of surgical staging.
Women who have resection of microscopic (less than 5 mm in size) metastatic paraaortic nodes followed by extended field radiation have a survival equal to women who have negative paraaortic nodes.
Staging and resection of nodes by laparotomy has been used since the 1970s; however, radiation-induced intestinal complications diminished its therapeutic advantage.
The development of laparoscopic techniques has markedly decreased these complications and has led to many institutions to perform standard surgical staging.
Anatomic Considerations
Laparoscopic paraaortic node dissection can be performed by either transperitoneal or extraperitoneal techniques.
The anatomic boundaries have been described in chapters 9 and 14.
IMAGING AND OTHER DIAGNOSTICS
Clinical staging of cervical cancer is accurate in 85% of stage 1B but drops to 35% in stage 2A, and to 21% in stage 2B.
Imaging with MRI is the most accurate means of detecting the size of the lesion, depth of invasion, parametrial invasion, and extension to the uterus.
PET/CT is most accurate in detecting nodal or other metastatic diseases.
Early-stage cervical cancer stage 1A2 and 1B1 have such a low rate of detectable metastases that pretreatment PET/CT is not indicated.
Patients with locally advanced cervical cancer defined as stage 1B2 through stage 4 may benefit from PET/CT if metabolically active enlarged nodes are identified.
When PET/CT is compared with surgical staging, the falsenegative rate is 12%.
Surgical staging has found paraaortic node positivity in 6% of stage 1B, 12% of stage 2A, 19% of stage 2B, 33% of stage 3A, 29% of stage 3B, and 30% of stage 4.
PREOPERATIVE PLANNING
The results of any images need to be reviewed and discussed with the patient. The goal of the surgery and the subsequent impact on the radiation will be discussed.
The images will indicate if there are enlarged nodes and where they are located so the surgeon will specifically look at those locations.
If no nodes are suspicious, then a standard node dissection will be planned.
SURGICAL MANAGEMENT
Obese patients will benefit from an extraperitoneal node dissection since the bowel will not be in the way.
Positioning
Those patients who will have a transperitoneal laparoscopic node dissection will be in the standard lithotomy position shown in other chapters.
The patient who will have a retroperitoneal dissection will be in the supine position with the left arm out. This will allow the trocars to be placed along the left flank. A tucked arm would be in the way of the surgery.
PROCEDURES AND TECHNIQUES
Transperitoneal Laparoscopic Node Dissection
The trocars are placed in position as in the images (Tech Figs. 21.1 and 21.2). The ancillary port at Palmer’s point will be used to lift up the peritoneum holding the duodenum and for removing the nodes.
The peritoneum is incised from the bifurcation of the aorta to the duodenum.
The right paraaortic node dissection is completed. See Chapter 12, Robotic Extrafascial Hysterectomy, for the description and Video 21.1 in an endometrial cancer patient.
The nodes below the inferior mesenteric artery are exposed by an incision along the base of the sigmoid mesentery.Stay updated, free articles. Join our Telegram channel
Full access? Get Clinical Tree